Clinical Trials Directory

Trials / Completed

CompletedNCT03409640

Metal-on-metal Hip Replacement MRI Study

The Rate of Symptomatic and Asymptomatic Non-malignant, Non-infective Soft Tissue Masses in Primary Metal on Metal Hip Replacement.

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is being conducted to determine the rate of symptomatic and asymptomatic nonmalignant, noninfective soft tissue mass presence (referred to in the literature as pseudotumour, ALVAL, ARMD, cysts or lesions) in primary metal on metal hip replacement patients. The primary objective of the study is to determine the prevalence of masses in unbiased Metal on Metal (MoM) samples drawn from one study centre. The subjects receiving the Metal on Metal devices will be observed at two specific time points. Secondary objectives are to evaluate whether the occurrence of masses is related to any of several potential factors including patient and implant characteristics and time since the implant procedure took place.

Conditions

Timeline

Start date
2014-01-17
Primary completion
2017-12-31
Completion
2017-12-31
First posted
2018-01-24
Last updated
2018-01-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03409640. Inclusion in this directory is not an endorsement.